TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2012 Financial Results

NEW YORK, Nov. 7, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that a conference call will be held on Friday, November 9, 2012 at 8:30 a.m. EST to discuss results for the third quarter ended September 30, 2012 and a business outlook for the remainder of 2012. Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.